N. Ruswa

DRUG-RESISTANT TUBERCULOSIS CASE-FINDING STRATEGIES: A SCOPING REVIEW PROTOCOL

S. Shah, S. Niemann, N. Gandhi, 2022, medRxiv.

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia

B. Godman, D. Kibuule, T. Rennie, 2020, ERJ Open Research.

Drug-resistant tuberculosis: advances in diagnosis and management

P. Keller, G. Günther, N. Ruswa, 2022, Current opinion in pulmonary medicine.

Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.

B. Godman, D. Kibuule, T. Rennie, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review

S. Niemann, Hsien-Ho Lin, N. Gandhi, 2022, JMIR Research Protocols.

Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection

A. Mantel‐Teeuwisse, N. Ruswa, E. Sagwa, 2013, Drug Safety.

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

H. Leufkens, A. Mantel‐Teeuwisse, T. Rennie, 2015, BMC Pharmacology and Toxicology.

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

H. Leufkens, A. Mantel‐Teeuwisse, T. Rennie, 2015, BMC Pharmacology and Toxicology.

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

H. Leufkens, A. Mantel‐Teeuwisse, T. Rennie, 2016, Patient preference and adherence.

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia

S. Pal, A. Mantel‐Teeuwisse, B. V. van Wyk, 2012, Southern med review.

Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia

S. Niemann, V. Dreyer, G. Günther, 2022, Microbiology spectrum.

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

A. Mantel‐Teeuwisse, N. Ruswa, E. Sagwa, 2014, Journal of pharmaceutical policy and practice.

TB Control in Namibia 2002-2011: Progress and Technical Assistance

F. Mavhunga, Rosalia Indongo, B. Schreuder, 2013 .

Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys

D. Lolong, S. Egwaga, A. Copas, 2023, EClinicalMedicine.